An immunologist’s question
By Raheleh Shayan, PhD , an immunologist with twenty-five years in cellular and molecular biology, across academic research, industry and contract research.
About GENXMAP
GENXMAP is molecular biology crossed with computational biology.
GENXMAP is a multi-omics R&D laboratory in Marseille. Wet lab, bioinformatics and AI work as one team, so every analytical decision is made with the full picture of the project, not just the file that was handed over.
Our approach
Biological research has split into three trades. A study can pass through several laboratories, a sequencing provider and an analysis team, each step technically sound, and still lose its biological context between them.
GENXMAP was built to keep the three together, from study design and sample processing, through molecular characterization, to analysis and interpretation, so that a program produces coherent evidence rather than a set of datasets.
Our story
By Raheleh Shayan, PhD , an immunologist with twenty-five years in cellular and molecular biology, across academic research, industry and contract research.
The laboratory built up over two years: techniques and technologies brought in-house, and the first services structured.
Joined Marseille Innovation, AFSSI and the wider Provence life-sciences network.
Laboratories integrated within the IHU Méditerranée Infection environment; public and private partnerships developed.
Own research programs launched, and dry-lab and analysis capacity built alongside the bench.
Client portal launched; proteomics platform established on site; membership of the Paris-Saclay Cancer Cluster and the Marseille Immunology Biocluster.
Wet lab, bioinformatics and AI under one roof, and one scientific project lead per program.
Recognition
French status for companies whose research is a major share of their spending.
Our R&D programsApproved by the French Ministry of Research to carry out R&D on behalf of companies. Eligibility is assessed project by project.
Research tax creditAn R&D program funded under France 2030 (PIA4, regional component), operated by Bpifrance. Member of the French Tech Aix-Marseille community.
Funded programsOur network
A selection of our network: key partners and institutions.
Laboratories at IHU Méditerranée Infection, Marseille.
Reception, extraction and QC run in-house, and bulk RNA-seq on site, at IHU Méditerranée Infection.
Some specialist steps are run by partners under your study plan, coordinated by GENXMAP, as in our combo platforms.
IHU Méditerranée Infection, Marseille Medical Genetics and Eurobiomed make up our consortium network; our R&D programs are backed by Bpifrance and France 2030.
GENXMAP is a member of the Paris-Saclay Cancer Cluster and of the Marseille Immunology Biocluster.
Our laboratories and platforms



In Marseille
Marseille brings together hospitals, research institutes and universities within a few streets: IHU Méditerranée Infection, Aix-Marseille University, Inserm and Marseille Medical Genetics. For our clients, that means clinical expertise, cohorts and specialized platforms close at hand. More on our Marseille site.
Where samples are received: GENXMAP, 19-21 boulevard Jean Moulin, IHU Méditerranée Infection, 13005 Marseille, in the Timone hospital district. The address for a given shipment is confirmed in your quote.
For contracts and invoicing only, an administrative address, no samples: 9 rue Jacques Réattu, 13009 Marseille.
Carrier shipments across France and the European Union, on dry ice or at ambient temperature depending on the material. Conditions by sample type are on the sample shipping page.
For teams in Marseille and the Provence-Alpes-Côte d’Azur region, which removes a carrier step for fragile material or short collection windows.
Samples and data
Set per study, written into the contract, and the same whoever runs the bench work.
Patient-derived and clinical samples are handled under the consent and bioethics framework applicable to each study.
Processed within the European Union, depending on the sensitivity of the data and the client’s requirements.
No exception, whichever platform or partner runs the measurement.
Access controlled per project; retention set by the study contract.
Case studies
CASE STUDY · SKIN BIOLOGY · HEALTHY AGINGFrom molecules to claims: characterizing the mechanism of an active positioned for skin longevityKey result4 supported2 supported with restricted wording · 1 not supportedIllustrative scenario · not a client projectRead the case study
CASE STUDY · IMMUNO-ONCOLOGYFinding, and confirming, markers of response to checkpoint blockadeKey resultheld-out AUC 0.78vs 0.62 for PD-L1 IHC aloneIllustrative scenario · not a client projectRead the case study
CASE STUDY · MICROBIOME · GUT–BRAIN AXISFollowing the gut–brain chain: what a probiotic changes, and how the host respondsKey result82%of the probiotic arm carried the strains at week 8, only 9% four weeks after stoppingIllustrative scenario · not a client projectRead the case study Have a biological question?